Literature DB >> 8414013

Antecedent clinical features associated with dementia in Parkinson's disease.

Y Stern1, K Marder, M X Tang, R Mayeux.   

Abstract

In a prospective cohort study, we examined clinical features in 250 nondemented patients with idiopathic Parkinson's disease (PD) and then evaluated their association with incident dementia during 5 years of follow-up. Seventy-four of the patients became demented. Odds ratios for incident dementia with PD were increased for the following: being older than 70 years of age (2.7; 1.4 to 5.5), having a PD rating scale score greater than 25 (3.0; 1.5 to 6.2), being depressed (2.7; 1.5 to 6.6), being confused or psychotic on levodopa (3.3; 1.3 to 8.7), or having facial masking as a presenting sign (6.1; 1.4 to 26.9).

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8414013     DOI: 10.1212/wnl.43.9.1690

Source DB:  PubMed          Journal:  Neurology        ISSN: 0028-3878            Impact factor:   9.910


  22 in total

Review 1.  Neuropsychiatric aspects of Parkinson's disease.

Authors:  D Aarsland; K Karlsen
Journal:  Curr Psychiatry Rep       Date:  1999-10       Impact factor: 5.285

Review 2.  Neuropsychiatry of the basal ganglia.

Authors:  H A Ring; J Serra-Mestres
Journal:  J Neurol Neurosurg Psychiatry       Date:  2002-01       Impact factor: 10.154

3.  Neuropsychology, neuroimaging or motor phenotype in diagnosis of Parkinson's disease-dementia: which matters most?

Authors:  Francesca Di Biasio; Nicola Vanacore; Alfonso Fasano; Nicola Modugno; Barbara Gandolfi; Francesco Lena; Giovanni Grillea; Sara Pietracupa; Giovanni Caranci; Stefano Ruggieri
Journal:  J Neural Transm (Vienna)       Date:  2011-12-13       Impact factor: 3.575

4.  CSF amyloid {beta} 1-42 predicts cognitive decline in Parkinson disease.

Authors:  A Siderowf; S X Xie; H Hurtig; D Weintraub; J Duda; A Chen-Plotkin; L M Shaw; V Van Deerlin; J Q Trojanowski; C Clark
Journal:  Neurology       Date:  2010-08-18       Impact factor: 9.910

5.  A differential deficit in time- versus event-based prospective memory in Parkinson's disease.

Authors:  Sarah A Raskin; Steven Paul Woods; Amelia J Poquette; April B McTaggart; Jim Sethna; Rebecca C Williams; Alexander I Tröster
Journal:  Neuropsychology       Date:  2011-03       Impact factor: 3.295

Review 6.  MDS Task Force on mild cognitive impairment in Parkinson's disease: critical review of PD-MCI.

Authors:  Irene Litvan; Dag Aarsland; Charles H Adler; Jennifer G Goldman; Jaime Kulisevsky; Brit Mollenhauer; Maria C Rodriguez-Oroz; Alexander I Tröster; Daniel Weintraub
Journal:  Mov Disord       Date:  2011-06-09       Impact factor: 10.338

7.  Neuropsychological prediction of dementia in Parkinson's disease.

Authors:  F Mahieux; G Fénelon; A Flahault; M J Manifacier; D Michelet; F Boller
Journal:  J Neurol Neurosurg Psychiatry       Date:  1998-02       Impact factor: 10.154

8.  Genetic influences on cognitive decline in Parkinson's disease.

Authors:  James F Morley; Sharon X Xie; Howard I Hurtig; Matthew B Stern; Amy Colcher; Stacy Horn; Nabila Dahodwala; John E Duda; Daniel Weintraub; Alice S Chen-Plotkin; Vivianna Van Deerlin; Dana Falcone; Andrew Siderowf
Journal:  Mov Disord       Date:  2012-02-16       Impact factor: 10.338

9.  Forebrain overexpression of alpha-synuclein leads to early postnatal hippocampal neuron loss and synaptic disruption.

Authors:  Youngshin Lim; Vicky M Kehm; Chi Li; John Q Trojanowski; Virginia M-Y Lee
Journal:  Exp Neurol       Date:  2009-10-13       Impact factor: 5.330

10.  Anticholinergic therapy and dementia in patients with Parkinson's disease.

Authors:  M Pondal; T Del Ser; F Bermejo
Journal:  J Neurol       Date:  1996-07       Impact factor: 4.849

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.